PMC:7166029 / 10706-10978 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"268","span":{"begin":243,"end":261},"obj":"Gene"},{"id":"269","span":{"begin":10,"end":18},"obj":"Species"},{"id":"270","span":{"begin":56,"end":64},"obj":"Species"},{"id":"271","span":{"begin":139,"end":147},"obj":"Species"},{"id":"272","span":{"begin":213,"end":220},"obj":"Species"},{"id":"273","span":{"begin":24,"end":32},"obj":"Disease"}],"attributes":[{"id":"A268","pred":"tao:has_database_id","subj":"268","obj":"Gene:1401"},{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"Tax:9606"},{"id":"A270","pred":"tao:has_database_id","subj":"270","obj":"Tax:9606"},{"id":"A271","pred":"tao:has_database_id","subj":"271","obj":"Tax:9606"},{"id":"A272","pred":"tao:has_database_id","subj":"272","obj":"Tax:9606"},{"id":"A273","pred":"tao:has_database_id","subj":"273","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T78","span":{"begin":82,"end":92},"obj":"Body_part"},{"id":"T79","span":{"begin":165,"end":175},"obj":"Body_part"},{"id":"T80","span":{"begin":254,"end":261},"obj":"Body_part"}],"attributes":[{"id":"A78","pred":"fma_id","subj":"T78","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A79","pred":"fma_id","subj":"T79","obj":"http://purl.org/sig/ont/fma/fma62861"},{"id":"A80","pred":"fma_id","subj":"T80","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T80","span":{"begin":24,"end":32},"obj":"Disease"}],"attributes":[{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T119","span":{"begin":204,"end":206},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T92","span":{"begin":254,"end":261},"obj":"Chemical"}],"attributes":[{"id":"A92","pred":"chebi_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-sentences","denotations":[{"id":"T107","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T13","span":{"begin":155,"end":182},"obj":"Phenotype"}],"attributes":[{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0031891"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T211","span":{"begin":24,"end":32},"obj":"SP_7"},{"id":"T212","span":{"begin":82,"end":92},"obj":"CL:0000542"},{"id":"T213","span":{"begin":165,"end":175},"obj":"CL:0000771"},{"id":"T214","span":{"begin":245,"end":261},"obj":"PR:000005897"},{"id":"T63081","span":{"begin":10,"end":20},"obj":"CL:0000542"},{"id":"T69953","span":{"begin":93,"end":101},"obj":"CL:0000771"},{"id":"T70699","span":{"begin":171,"end":189},"obj":"PR:000005897"},{"id":"T50652","span":{"begin":242,"end":253},"obj":"NCBITaxon:11118"}],"text":"In the 32 patients with COVID-19, 15 (47%) and 16 (50%) patients showed decreased lymphocyte counts and proportions, 21 (66%) and 24 (75%) patients showed decreased eosinophil counts and proportions, and 18 (56%) patient showed an increase in C-reactive protein (Fig. 2 )."}